Back
Global Medical REIT 10K Form
Sell
30
GMRE
Global Medical REIT
Last Price:
$8.72
Seasonality Move:
2.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-05-07 | 10Q | GMRE/Global Medical REIT Quarterly |
2021-03-08 | 10K | GMRE/Global Medical REIT Annual |
2020-11-06 | 10Q | GMRE/Global Medical REIT Quarterly |
2020-08-07 | 10Q | GMRE/Global Medical REIT Quarterly |
2020-05-08 | 10Q | GMRE/Global Medical REIT Quarterly |
2020-04-27 | 10K | GMRE/Global Medical REIT Annual |
Receive GMRE News And Ratings
See the #1 stock for the next 7 days that we like better than GMRE
GMRE Financial Statistics
Sales & Book Value
Annual Sales: | $138.4M |
---|---|
Cash Flow: | $-33.3M |
Price / Cash Flow: | 24.65 |
Annual Sales: | $6.87 |
Price / Book: | 1.28 |
Profitability
EPS (TTM): | 0.01000 |
---|---|
Net Income (TTM): | $6.6M |
Gross Margin: | $109.2M |
Return on Equity: | 1.14% |
Return on Assets: | 0.53% |
Global Medical REIT Earnings Forecast
Key Global Medical REIT Financial Ratios
-
The Gross Profit Margin over the past 11 years for GMRE is 78.87%.
-
The Selling, General & Administrative Expenses for GMRE have been equal to 15.26% of Gross Profit Margin.
-
The Interest Expense is 432.52% of Operating Income.
-
The Net Earning history of GMRE is 4.79% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 8 years.
Global Medical REIT Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care REITs |
Sector: | Real Estate |
Current Symbol: | GMRE |
CUSIP: | 37954A |
Website: | globalmedicalreit.com |
Debt
Debt-to-Equity Ratio: | 1.21 |
---|---|
Current Ratio: | 0.03 |
Quick Ratio: | 0.02 |
Price-to-Earnings
Trailing P/E Ratio: | 877 |
---|---|
Forward P/E Ratio: | 16.24 |
GMRE Technical Analysis vs Fundamental Analysis
Sell
30
Global Medical REIT (GMRE)
is a Sell
Is Global Medical REIT a Buy or a Sell?
-
Global Medical REIT stock is rated a SellThe current Global Medical REIT [GMRE] share price is $8.77. The Score for GMRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.